The ATS 2026 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert sessions addressing new developments and considerations in the fields of allergy and immunology, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the ATS365 platform. For more information on these and other sessions to be presented May 15–20 in Orlando, Fla., visit the online Advance Program.
- PG15 ASTHMA AND BEYOND: MOLECULAR MECHANISMS, PHYSIOLOGY, AND TREATMENT
- A14 SEPSIS AND THE INJURED LUNG: DEFINING MECHANISMS AND IMPROVING PATIENT SURVIVAL
- A22 IMMUNOLOGICAL INSIGHTS IN ILD AND TRANSPLANT OUTCOMES
- A35 DECODING PARENCHYMAL LUNG DISEASE: INTERSTITIAL AND VASCULITIC INSIGHTS
- A33 FROM THE DARK SIDE TO THE LUNG SIDE: THE EPIC BATTLE AGAINST ARDS AND INFECTION
- A34 CHARTING THE UNSEEN TRAILS LEADING TO COPD
- A32 MAPPING THE ASTHMA LANDSCAPE: A DEEP DIVE INTO COMPREHENSIVE PHENOTYPING AND INHALED INNOVATIONS
- A10 IS IT SARCOIDOSIS? – I DON’T KNOW
- A93 THE INTERSECTION OF IMMUNITY AND FIBROSIS: EXPOSURES AND MECHANISTIC OUTCOMES IN INTERSTITIAL LUNG DISEASE
- A90 ONE AIRWAY, MANY OUTCOMES: RETHINKING ASTHMA AND COPD ACROSS THE LIFESPAN
- B15 PRECISION MEDICINE FOR COPD: CHARTING THE COURSE FOR NOVEL TREATMENTS AND CLINICAL SUCCESS
- B22 IT AIN’T EASY BEING WHEEZY: WHY AND WHAT’S NEW IN ASTHMA TREATMENTS
- B34 FRONTIERS IN LUNG TRANSPLANT: EXPLORING IMMUNITY AND REJECTION
- B35 RARE AIR: JUMPING INTO UNIQUE CASES OF INTERSTITIAL LUNG DISEASE AND VASCULITIS
- B33 UNRAVELING THE OMIC LAYERS: TRANSLATIONAL INSIGHTS IN AIRWAYS DISEASE
- B32 RISE OF THE BIOLOGICS: A NEW HOPE FOR BREATHING EASIER
- B6 OMICS TO ACTION: REDESIGNING TRIALS AND CARE IN RESPIRATORY MEDICINE
- C15 MICROBIAL MAESTROS: TOWARDS MECHANISMS OF MICROBIOME INFLUENCE IN LUNG DISEASE
- C14 STRENGTHENING YOUR “-ABS” AND MORE: ASTHMA THERAPEUTICS AND OUTCOMES
- C32 NAVIGATING IMMUNITY: A CLINICAL DIVE INTO ALLERGIC PHENOMENON AND IMMUNE DEFICIENCIES
- C33 FROM DATA TO BREATHS: STORIES OF ASTHMA UNFOLDED
- C34 ASTHMA UNVEILED: A THEMATIC JOURNEY FROM OMICS TO PRECISE CHARACTERIZATION OF PHENOTYPE AND THERAPIES
- MTE32 MODELING THE DISEASED LUNG MICROENVIRONMENT: EXPERIMENTAL STRATEGIES FOR COMPLEX CO-MORBID CONDITIONS
- C101 THE COPD RUBIX CUBE: ‘OMICS AND MECHANISMS
- D21 TYPE 2 IMMUNITY AND BEYOND: ASTHMA MECHANISMS AND TARGETS
- D91 INFECTION, IMMUNITY, INTERVENTIONS: VIRUSES, BACTERIA, AND BRONCHIECTASIS OUTCOMES
- D101 INFLAMMATION AND RESILIENCE: HOST RESPONSES IN LUNG INJURY AND INFECTION
- D85 AIMING HIGHER: THE JOURNEY TOWARD ASTHMA REMISSION
Don’t Miss the ATS 2026 International Conference
Register today for the ATS 2026 International Conference to experience this year’s premier respiratory health conference, May 15-20 in Orlando. Join your colleagues to learn about the latest developments in pulmonary, critical care, and sleep medicine.
Not an ATS member? Join today and save on your conference registration!